This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Z.-Q. Articles by Carey, R. M. Search for Related Content PubMed PubMed Citation Articles by Wang, Z.-Q. Articles by Carey, R. M.

(Hypertension. 1998;32:78-83.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Immunolocalization of Subtype 2 Angiotensin II (AT₂) Receptor Protein in Rat Heart

Zhi-Qin Wang; Allan F. Moore; Ryoji Ozono; Helmy M. Siragy; ; Robert M. Carey

From the Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Va.

Correspondence to Robert M. Carey, MD, Box 395, University of Virginia Health Sciences Center, Charlottesville, VA 22908. E-mail RMC4C{at}virginia.edu

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Abstract—Angiotensin II exerts its effects on cardiovascular function and water and sodium homeostasis by interacting with plasma membrane receptors on target organs. The existence of subtype 2 angiotensin II (AT₂) receptors in the rat heart has been demonstrated by ligand binding and reverse transcription–polymerase chain reaction. In the present study, the expression and localization of AT₂ receptor protein in the rat heart was investigated using an antipeptide polyclonal antibody against the native rat AT₂ receptor by light microscopic immunocytochemistry and Western blot analysis. In frozen tissue sections, positive immunostaining was observed in the myocardium and coronary vessels throughout the ventricle and atrium of neonatal and young rat hearts. Coronary vessels of the neonatal heart were more intensely stained compared with the surrounding myocardium. Positive immunoreactivity in the coronary vessels of young rats was localized to vascular endothelium but not in the smooth muscle cells. Preadsorption controls were all negative. Western blot analysis showed that the AT₂ receptor protein (44 kDa) was detectable from the AT₂ receptor–transfected COS-7 cells and neonatal rat cardiac myocytes but not from fibroblasts or young rat aortic smooth muscle cells. The neonatal rat heart expressed significantly more AT₂ receptors than young rat heart. These data provide the first direct evidence for the expression and localization of AT₂ receptor protein in the rat heart.

Key Words: receptors, angiotensin II • heart • immunocytochemistry • myocardium • rats

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Angiotensin II (Ang II) plays an important role in the maintenance of cardiovascular homeostasis by controlling vascular tone, sodium excretion, hormone secretion, and neuronal activity. Ang II exerts major influences on the heart via its effects on systemic hemodynamics and blood volume. Two pharmacologically distinct subclasses of Ang II receptor, types 1 and 2 (AT₁ and AT₂), have been identified based on their inhibition by the nonpeptide antagonists losartan (AT₁) and PD 123319 (AT₂).^{1 2} The cDNAs of both receptor subtypes have been cloned and sequenced. Although they both have a seven-transmembrane domain structure typical of G protein–coupled receptors, AT₁ and AT₂ receptors have only 34% homology at the protein level and display different functional properties and signal transduction mechanisms.³ The AT₁ receptor is localized to the brain, heart, kidney, peripheral vasculature, and adrenal glands.⁴ In contrast, the AT₂ receptor is abundantly and widely expressed in fetal tissues but is present only at low levels in limited organs in adults, including the brain, adrenal glands, uterine myometrium, and atretic ovarian follicles.^{5 6 7 8} Almost all of the known physiological effects of Ang II are mediated through the AT₁ receptor. The biological role associated with the AT₂ receptor remains to be established. Recently, the AT₂ receptor has been shown to be reexpressed/upregulated in experimental cardiac hypertrophy, myocardial infarction, and neointimal lesions after vascular injury and skin wounds.^{9 10 11 12}

The expression of cardiac AT₁ receptor mRNA and binding sites have been localized to cardiac myocytes, fibroblasts, endothelial cells, presynaptic neurons, and conducting tissue in the heart.^{13 14 15 16 17 18} In contrast, studies localizing the AT₂ receptor in the heart are largely limited to ligand binding and autoradiography studies, which have shown low levels of expression.^{14 15 16 17 18} One recent study using an in situ hybridization technique reported that AT₂ receptor mRNA was observed only in the coronary artery but not in the myocardium in the developing rat heart.¹⁹ The regional distribution of this subtype receptor in the heart has not been fully explored. In the present study, we used a specific polyclonal rabbit antipeptide antibody, directed against a synthetic peptide that corresponds to the NH-terminal extracellular tail of the native rat AT₂ receptor cDNA, to determine AT₂ receptor protein expression and its localization in the neonatal (1 day after birth) and young (4-week-old) rat heart.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
All experiments were conducted with the approval of the Animal Research Committee of the University of Virginia School of Medicine.

Characterization of AT₂ Receptor Antiserum
AT₂ receptor–specific polyclonal antibody was raised in rabbits against a synthetic peptide sequence derived from the NH-terminal extracellular tail (MKDNFSFAATSRNITSS, amino acids 1 to 17) of the native rat AT₂ receptor.²⁰ Antibody specificity has been documented previously²⁰ by its ability to identify AT₂ receptor protein expressed in COS-7 cells stably transfected with a 2.9-kb full-length rat AT₂ receptor cDNA from PC12W cells (a rat pheochromocytoma cell line; a generous gift from Dr Inagami, Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn). This rat AT₂ receptor cDNA encodes a protein with 363 amino acid residues corresponding to a theoretical molecular weight of 41 303.^{21 22} These transfected cells have previously been shown to exhibit a high level of AT₂ receptor expression, specific receptor-ligand binding, and functional features characteristic of the AT₂ receptor.^{3 21}

Light Microscopic Immunocytochemistry
Timed pregnant and 4-week-old (70 to 100 g body weight) female Sprague-Dawley rats were obtained (Hilltop Laboratory Animals, Scottsdale, Pa). Neonatal rats were subjected to study at the age of 1 day. Rats were deeply anesthetized with pentobarbital sodium (80 mg/kg body wt IP). After a perfusion fix with 1% paraformaldehyde, or without perfusion in neonatal rats, the hearts were excised and fixed with 1% paraformaldehyde in PBS for 2 hours. Tissues were then cryoprotected overnight at 4°C in 30% sucrose in PBS, and frozen sections (10 to 12 µm) were cut. Immunoperoxidase immunocytochemistry was performed as previously described.^{20 23} After endogenous peroxidase was quenched by 0.3% H₂O₂ in methanol, the sections were blocked using 3% normal goat serum and 1% nonfat dry milk in PBS. Sections were then incubated overnight at 4°C with one of the following, diluted (1:500) in 1.5% normal goat serum and 0.5% nonfat dry milk in PBS: (1) AT₂ receptor primary antiserum (3.1 protein mg/mL) and (2) AT₂ receptor primary antiserum preadsorbed against its synthetic peptide antigen. For preadsorption, antiserum was incubated overnight at 4°C with a 10-fold molar excess of the pure peptide immunogen. After washes in PBS, the immunostaining was detected with an avidin-biotin immunoperoxidase reaction (Vectastain ABC kit, Vector Laboratory) and visualized by diaminobenzidine staining. Tissue sections were lightly counterstained with hematoxylin, dehydrated, and placed under coverslips.

Western Blot Analysis of AT₂ Receptor Protein
Western blot analysis was performed as previously described.^{20 23} AT₂ receptor–transfected or –nontransfected COS-7 cells, primary cultures of neonatal rat ventricular myocytes and fibroblasts^{24 25} (kindly provided by Dr K.M. Baker, Weis Center for Research, Danville, Pa), and young rat aortic smooth muscle cells²⁶ (kindly provided by Dr A. Hassid, Department of Physiology and Biophysics, University of Tennessee School of Medicine, Memphis) were extracted with lysis buffer (50 mmol/L Tris-HCl, 150 mmol/L NaCl, 0.02% sodium azide, 100 µg/mL PMSF, 1 µg/mL aprotinin, 1% NP-40) and then centrifuged. The supernatant was stored at -70°C until the time of the experiment. After rats were deeply anesthetized, tissues (heart, adrenal gland, and whole brain) were dissected, minced, and immediately homogenized with Polytron in Buffer A (10% glycerol, 20 mmol/L Tris-HCl, 100 mmol/L NaCl, 2 mmol/L PMSF, 2 mmol/L EDTA, 2 mmol/L EGTA, 10 mmol/L sodium orthovanadate, 10 µg/L leupeptin, 10 µg/L aprotinin). The homogenate was centrifuged. The resultant pellet was resuspended in Buffer B (Buffer A with 1% NP-40), stirred, and centrifuged again. The supernatant was stored at -70°C until analysis.

Aliquots of solubilized samples were separated by SDS–polyacrylamide gel electrophoresis (5% acrylamide stacking gel and 8% running gel). Proteins were transferred onto a nitrocellulose membrane (0.2 µm, Schleicher & Schuell) by semidry electroblotting (Trans Blot SD DNA, Bio-Rad). The nitrocellulose membrane was soaked in Tris-buffered saline (TBS; 10 mmol/L Tris-HCl, 250 mmol/L NaCl) containing 5% nonfat powdered milk and 0.1% Tween 20 to block nonspecific sites and then incubated with the AT₂ receptor antiserum (3.1 mg/mL, 1:1000 dilution in TBS with 5% nonfat milk and 0.1% Tween 20). Blots were washed, incubated with peroxidase-conjugated donkey anti-rabbit secondary antibody (1:5000 dilution, Amersham). Immunoreactivity was visualized with an ECL Western blotting detection kit (Amersham).

Protein concentrations were determined by micro-bicinchoninic acid protein assay (Pierce). Quantitative assessment of band densities was performed by scanning densitometry (ImageQuant, Molecular Dynamics). Data were expressed as mean±SE and analyzed by Student's paired t test.

	Results

Top Abstract Introduction Methods Results Discussion References

 
In frozen sections, positive immunostaining for the AT₂ receptor was observed in the myocardium and coronary vessels throughout the ventricle and atrium of the neonatal (Figure 1A) and young (Figure 2A, 2C, and 2E) rat heart. In the neonatal heart, the coronary vessels were more intensely stained compared with the surrounding myocardium (Figure 1A). The positive immunoreactive signal in the intracardiac vessels comes from vascular endothelium but not smooth muscle cells (Figure 2E). Consecutive sections processed with the antibody preadsorbed against its peptide antigen at the same dilution as the anti-AT₂ receptor serum did not produce significant staining (Figure 1B, Figure 2B and 2D).

View larger version (139K): [in this window] [in a new window]   Figure 1. Light photomicrographs of frozen sections of the neonatal rat heart. Positive immunostaining for the AT2 receptor was noted in the myocardium and coronary vessels in the neonatal heart (A); corresponding preadsorption control (B) showed absence of staining (magnification x800).

View larger version (162K): [in this window] [in a new window]   Figure 2. Light photomicrographs of frozen sections of the young (4-week-old) rat heart. Positive immunostaining for the AT2 receptor was present in the myocardium and coronary vessels in both atrium (A) and ventricle (C); corresponding preadsorption controls (B and D) showed absence of staining (magnification x400). Positive immunoreactive signal was detected in the coronary vascular endothelium but not smooth muscle cells (E) (magnification x800).

On the immunoblot, the AT₂ receptor protein (44 kDa) was detected from the AT₂ receptor–transfected COS-7 cells and neonatal cardiac myocytes but not from neonatal cardiac fibroblasts or young rat aortic smooth muscle cells (Figure 3). This band was observed in membranes from the whole hearts of neonatal and young rats. Moreover, in all seven comparisons, the density of this specific band in the neonatal heart was significantly greater than in the young rat heart by semiquantitative analysis (Figure 4).

View larger version (52K): [in this window] [in a new window]   Figure 3. Western blot analysis of the AT2receptor (10 µg protein loaded per lane). The AT2 receptor protein was detected at 44 kDa in membranes from AT2 receptor–transfected COS-7 cells (left, lane 3) and neonatal cardiac myocytes (right, lane 1). This band was not present in membranes from nontransfected COS-7 cells (left, lane 2), young rat aortic smooth muscle cells (left, lane 1), or neonatal cardiac fibroblasts (right, lane 2). Migration and size of molecular weight markers (MW, values x103) are at left.

View larger version (32K): [in this window] [in a new window]   Figure 4. Western blot analysis comparing expression of the cardiac AT2 receptor in neonatal (lane 1) and young (lane 2) rats (30 µg protein loaded per lane). Left, Representative immunoblot. Migration and size of molecular weight markers (MW, values x103) are at left. Right, Summary of densitometry quantitation of seven separate experiments. **P<0.01 vs neonate.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
We characterized the site-specific distribution of the AT₂ receptor protein in the neonatal and young rat heart using a specific polyclonal antipeptide antibody. The specificity of the antiserum used was validated by (1) positive immunostaining of AT₂ receptor–transfected COS-7 cells and absence of staining in preadsorption control and nontransfected COS-7 cells in our previous study²⁰ ; (2) the presence of a single band of the appropriate molecular mass (44 kDa) in COS-7 cells stably transfected with the native AT₂ receptor and its absence in nontransfected COS-7 cells or adult rat aortic smooth muscle cells, which have been shown to express Ang II receptors of AT₁ but not AT₂ subtype^{11 27} ; and (3) the presence of the same single band in rat adrenal gland and brain,²⁰ tissues known to have abundant expression of the AT₂ receptor.^{6 28 29} Therefore, these results confirm that the antipeptide serum, directed toward a completely conserved region of the AT₂ receptor, can recognize in an effective and selective manner its appropriate peptide antigen in both transfected cells and experimental tissues.

Our results in the present study are different from those of Reagan et al,³⁰ who described two bands (110 and 66 kDa) recognized by a protein-directed polyclonal AT₂ receptor antiserum against a partially purified membrane protein from murine neuroblastoma N1E-115 cells. It is not clear to which amino acid sequence of the cell membrane protein their antiserum was directed, whereas our antibody was raised against a specific peptide sequence of the cloned rat AT₂ receptor. The different species and immunogen used by Reagan et al could have accounted for the finding of higher molecular mass bands of mouse AT₂ receptor protein than the presently observed molecular weight of the native rat AT₂ receptor. Interestingly, no immunospecific proteins were detected by their antiserum in rat adrenal gland and PC12W cells, as well as in COS-1 cells transfected with the mouse AT₂ receptor cDNA from N1E-115 cells.^{31 32} This lack of immunoreaction with the recently cloned rat AT₂ receptor was interpreted as being due to the possible heterogeneity within the AT₂ receptor subtype.^{31 32 33}

During the late embryonic and early postnatal periods, cells in the myocardium undergo a transition from growth by an increase in cell number to growth by an increase in cell size, and rapid vascular growth and capillary formation also occur in the developing rat heart. Previous studies using autoradiography and in situ hybridization techniques showed that high concentrations of AT₂ receptor mRNA and binding sites are present in the vasculature of the newborn rat heart.^{19 34} While the existence of AT₂ receptor mRNA and binding sites has been demonstrated in neonatal rat cardiomyocytes,^{17 35} Ang II receptor binding sites found on the neonatal cardiac fibroblasts are mainly, if not exclusively, of the AT₁ subtype.^{18 25 35 36} Consistently, our present study demonstrated that the neonatal cardiac myocytes but not fibroblasts express AT₂ receptor protein. The AT₂ receptor protein exists not only in the myocardium but also in coronary vessels. Expression in the cardiac vasculature was significantly higher than in myocardium, which provides support for the hypothesis that Ang II may act as an angiogenic factor in the developing rat heart.

Studies using in situ hybridization and Northern blot analysis failed to generate detectable AT₂ receptor transcripts from adult rat hearts.^{19 21 37} Competitive reverse transcription–polymerase chain reaction, using total RNA prepared from adult rat hearts, revealed a detectable transcript for the AT₂ receptor gene.¹⁰ Quantitative autoradiography and radioligand binding studies both indicated that low levels of cardiac AT₁ and AT₂ receptor subtypes exist in essentially equal proportions in the adult rat heart,^{9 14 15} although 90% AT₂ binding sites in the rat heart also were reported.¹⁶ Our results show that AT₂ receptor protein in young rat heart was detectable in coronary vessels and myocardium but at a relatively lower level compared with neonatal heart. The positive immunoreactivity found in the coronary endothelial layer is in good agreement with results obtained from cultured coronary endothelial cells.^{38 39} The present immunoblotting results from vascular smooth muscle cells of the rat aorta confirmed that these cells do not normally express AT₂ receptor, as shown by our preliminary immunocytochemical study.⁴⁰ Further studies at the electron microscopic level would help to elucidate the exact cell type(s) with expression of AT₂ receptor in the heart.

The role of cardiac AT₂ receptors in control of heart function remains to be clarified. In isolated ischemic rat hearts, the cardioprotective effect of AT₁ receptor blockade may be mediated in part by endogenously released Ang II via AT₂ receptor stimulation.³⁹ The regression of hypertension-induced cardiac hypertrophy by AT₁ receptor antagonists may be due in part to an unopposed antigrowth effect of Ang II mediated via the AT₂ receptor.²⁴ Chronic AT₂ receptor antagonism blocked the improvement of cardiac function and regression of ventricular remodeling induced by AT₁ receptor antagonism in rats with chronic heart failure,⁴¹ whereas acute cardiac AT₂ receptor antagonism was shown to produce enhanced recovery from mechanical dysfunction after ischemia/reperfusion in isolated working rat hearts.⁴² Identification of the cardiac AT₂ receptor protein will help future exploration of the possible role of the AT₂ receptor in Ang II–mediated cardiovascular effects.

In summary, using a specific antipeptide polyclonal antibody directed toward the rat AT₂ receptor, we detected AT₂ receptor protein in the cardiac myocyte and coronary endothelium and provided evidence for the expression of AT₂ receptor protein in the coronary vessels and myocardium at a higher level in neonate than in young rats. These results support the hypothesis that expression of the cardiac AT₂ receptor protein is developmentally regulated and could therefore play a role in early cardiac growth and development.

	Acknowledgments

 
This work was supported in part by grants RO1-HL-49575 (Dr Carey) and R01-HL-47669 (Dr Siragy) from the National Institutes of Health. The authors wish to thank Drs Tadashi Inagami (Vanderbilt University School of Medicine, Nashville, Tenn), Kenneth M. Baker (Weis Center for Research, Danville, Pa), and Aviv Hassid (University of Tennessee School of Medicine, Memphis) for providing the AT₂ receptor–transfected COS-7 cells, neonatal rat ventricular myocytes and fibroblasts, and young rat aortic smooth muscle cells, respectively. Technical assistance from Suzanne J. Botkin and H. Beth McGrath is greatly appreciated.

Received February 4, 1998; first decision February 17, 1998; accepted February 25, 1998.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;163:284–291.[Medline] [Order article via Infotrieve]

2. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PB. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;165:196–203.[Medline] [Order article via Infotrieve]

3. Inagami T, Guo D-F, Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens. 1994;12(suppl 10):S83–S94.

4. Griendling KK, Lassehue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol. 1996;36:281–306.[Medline] [Order article via Infotrieve]

5. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT₂ receptors in the developing rat fetus. J Clin Invest. 1991;88:921–933.

6. Millan MA, Jacobowitz DM, Aguilera G, Catt KJ. Differential distribution of AT₁ and AT₂ angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci U S A. 1991;88: 11440–11444.

7. Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology. 1991;128:1947–1959.[Abstract/Free Full Text]

8. Tsutsumi K, Stromberg C, Viswanathan M, Saavedra JM. Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Endocrinology. 1991;129:1075–1082.[Abstract/Free Full Text]

9. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang S-S. Distribution and function of cardiac angiotensin AT₁- and AT₂-receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994;267:H844–H852.[Abstract/Free Full Text]

10. Nio Y, Matsubara H, Murasawa S, Kanasaski M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46–54.

11. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT₂) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663–10667.[Abstract/Free Full Text]

12. Viswanathan M, Saavedera JM. Expression of angiotensin II AT₂ receptors in the rat skin during experimental wound healing. Peptides. 1992;13:783–786.[Medline] [Order article via Infotrieve]

13. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smithm RD, Carsia RV. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205–251.[Medline] [Order article via Infotrieve]

14. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;71:1482–1489.[Abstract/Free Full Text]

15. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439–447.[Abstract/Free Full Text]

16. Chang RSL, Lotti VJ. Angiotensin receptor types in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci. 1991;49:1485–1490.[Medline] [Order article via Infotrieve]

17. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res. 1996;79:887–897.[Abstract/Free Full Text]

18. Crabos M, Roth M, Hahn AWA, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. J Clin Invest. 1994;93:2372–2378.

19. Shanmugam S, Corvol P, Gasc J-M. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension. 1996;28:91–97.[Abstract/Free Full Text]

20. Ozono R, Wang ZQ, Moore A, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT₂) receptor protein in rat kidney. Hypertension. 1997;30:1238–1246.[Abstract/Free Full Text]

21. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphate inhibition. J Biol Chem. 1993;268:24543–24546.[Abstract/Free Full Text]

22. Mukoyama M, Nakajiima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of a novel angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993;268:24539–24542.[Abstract/Free Full Text]

23. Ozono R, O'Connell DP, Wang ZQ, Morre AF, Sanada H, Felder RA, Carey RM. Localization of the dopamine D-1 receptor protein in the human heart and kidney. Hypertension. 1997;30:725–729.[Abstract/Free Full Text]

24. Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II–induced cardiomyocyte hypertrophy. Hypertension. 1996;28:635–640.[Abstract/Free Full Text]

25. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245–1254.[Abstract/Free Full Text]

26. Hassid A, Arabshahi H, Bourcier T, Dhaunsi GS, Matthews C. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol. 1994;267:H1040–H1048.[Abstract/Free Full Text]

27. Corriu C, Andre P, Schott C, Michel M, Stoclet JC. ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells. Am J Physiol. 1994;266:H631–H636.[Abstract/Free Full Text]

28. Shanmugam S, Llorens-Cortes C, Clauser E, Corvol P, Gasc J-M. Expression of angiotensin II AT₂ receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol. 1995;268:F922–F930.[Abstract/Free Full Text]

29. Zhuo J, Song K, Abdelrahman A, Mendelsohn FAO. Blockade by intravenous losartan of AT₁ angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol. 1994;21:557–567.[Medline] [Order article via Infotrieve]

30. Reagan LP, Theveniau M, Yang XD, Siemens IR, Yee DK, Reisine T, Fluharty SJ. Development of polyclonal antibodies against angiotensin type 2 receptors. Proc Natl Acad Sci U S A. 1993;90:7956–7960.[Abstract/Free Full Text]

31. Fluharty SJ, Reagan LP, Yee DK. The angiotensin type 1 and type 2 receptor families: siblings or cousins? Adv Exp Med Biol.. 1995;377:193–215.[Medline] [Order article via Infotrieve]

32. Reagan LP, Yee DK, He PF, Fluharty SJ. Heterogeneity of angiotensin type 2 (AT₂) receptors. Adv Exp Med Biol. 1996;396:199–208.[Medline] [Order article via Infotrieve]

33. Yee DK, He PF, Yang XD, Reagan LP, Hines J, Siemens IR, Fluharty SJ. Cloning and expression of angiotensin II type 2 (AT₂) receptors from murine neuroblastoma N1E-115 cells: evidence for AT₂ receptor heterogeneity. Mol Brain Res. 1997;45:108–116.[Medline] [Order article via Infotrieve]

34. Hunt RA, Ciuffo GM, Saavedra JM, Tucker DC. Quantification and localization of angiotensin II receptors and angiotensin converting enzyme in the developing rat heart. Cardiovasc Res. 1995;29:834–840.[Medline] [Order article via Infotrieve]

35. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest. 1994;93:1592–1601.

36. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849–2861.[Abstract/Free Full Text]

37. Everett AD, Fisher A, Tufro-McReddie A, Harris M. Developmental regulation of angiotensin type 1 and 2 receptor gene expression and heart growth. J Mol Cell Cardiol. 1997;29:141–148.[Medline] [Order article via Infotrieve]

38. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651–657.

39. Wiemer G, Scholkens BA, Wagner A, Heitsch H, Linz W. The possible role of angiotensin II subtype AT₂ receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens. 1993;11(suppl 5):S234–S235.

40. Ozono R, Oshima T, Kambe M, Carey RM. Decreased expression of type 2 angiotensin II receptor (AT₂) protein in left ventricular hypertrophy (LVH) in spontaneously hypertensive rats (SHR). Hypertension. 1997;30:507. Abstract.

41. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99:1926–1935.[Medline] [Order article via Infotrieve]

42. Ford WR, Clanachan AS, Jugdutt BI. Opposite effects of angiotensin AT₁ and AT₂ receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation. 1996;94:3087–3089.[Abstract/Free Full Text]

This article has been cited by other articles:

				A. K. Stennett, X. Qiao, A. E. Falone, V. V. Koledova, and R. A. Khalil Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H745 - H755. [Abstract] [Full Text] [PDF]

				C. Savoia, R. M. Touyz, M. Volpe, and E. L. Schiffrin Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients Hypertension, February 1, 2007; 49(2): 341 - 346. [Abstract] [Full Text] [PDF]

				K. Maitland, L. Bridges, W. P. Davis, J. Loscalzo, and M. A. Pointer Different Effects of Angiotensin Receptor Blockade on End-Organ Damage in Salt-Dependent and Salt-Independent Hypertension Circulation, August 29, 2006; 114(9): 905 - 911. [Abstract] [Full Text] [PDF]

				P. M. Abadir, A. Periasamy, R. M. Carey, and H. M. Siragy Angiotensin II Type 2 Receptor-Bradykinin B2 Receptor Functional Heterodimerization Hypertension, August 1, 2006; 48(2): 316 - 322. [Abstract] [Full Text] [PDF]

				M. Nakayama, X. Yan, R. L. Price, T. K. Borg, K. Ito, A. Sanbe, J. Robbins, and B. H. Lorell Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H317 - H327. [Abstract] [Full Text] [PDF]

				H. M. Siragy, C. Xue, P. Abadir, and R. M. Carey Angiotensin Subtype-2 Receptors Inhibit Renin Biosynthesis and Angiotensin II Formation Hypertension, January 1, 2005; 45(1): 133 - 137. [Abstract] [Full Text] [PDF]

				D. Kumar, V. Menon, W. R. Ford, A. S. Clanachan, and B. I. Jugdutt Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 285 - 296. [Abstract] [PDF]

				X. Yan, R. L. Price, M. Nakayama, K. Ito, A. J. T. Schuldt, W. J. Manning, A. Sanbe, T. K. Borg, J. Robbins, and B. H. Lorell Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2179 - H2187. [Abstract] [Full Text] [PDF]

				R. M. Carey and H. M. Siragy Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation Endocr. Rev., June 1, 2003; 24(3): 261 - 271. [Abstract] [Full Text] [PDF]

				S. Kurisu, R. Ozono, T. Oshima, M. Kambe, T. Ishida, H. Sugino, H. Matsuura, K. Chayama, Y. Teranishi, O. Iba, et al. Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis Hypertension, January 1, 2003; 41(1): 99 - 107. [Abstract] [Full Text] [PDF]

				Z. Cao, F. Bonnet, R. Candido, S. P. Nesteroff, W. C. Burns, H. Kawachi, F. Shimizu, R. M. Carey, M. de Gasparo, and M. E. Cooper Angiotensin Type 2 Receptor Antagonism Confers Renal Protection in a Rat Model of Progressive Renal Injury J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1773 - 1787. [Abstract] [Full Text] [PDF]

				Y. Xu, D. Kumar, J. R. B. Dyck, W. R. Ford, A. S. Clanachan, G. D. Lopaschuk, and B. I. Jugdutt AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1206 - H1215. [Abstract] [Full Text] [PDF]

				R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats Hypertension, December 1, 2001; 38(6): 1272 - 1277. [Abstract] [Full Text] [PDF]

				J. Deinum, J. M.G. van Gool, M. J.M. Kofflard, F. J. ten Cate, and A.H. J. Danser Angiotensin II Type 2 Receptors and Cardiac Hypertrophy in Women With Hypertrophic Cardiomyopathy Hypertension, December 1, 2001; 38(6): 1278 - 1281. [Abstract] [Full Text] [PDF]

				A. Sugawara, K. Takeuchi, A. Uruno, Y. Ikeda, S. Arima, M. Kudo, K. Sato, Y. Taniyama, and S. Ito Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-{{gamma}} in Vascular Smooth Muscle Cells Endocrinology, July 1, 2001; 142(7): 3125 - 3134. [Abstract] [Full Text] [PDF]

				J. Varagic, D. Susic, and E. D. Frohlich Coronary Hemodynamic and Ventricular Responses to Angiotensin Type 1 Receptor Inhibition in SHR : Interaction With Angiotensin Type 2 Receptors Hypertension, June 1, 2001; 37(6): 1399 - 1403. [Abstract] [Full Text] [PDF]

				A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF]

				L. Barlucchi, A. Leri, D. E. Dostal, F. Fiordaliso, H. Tada, T. H. Hintze, J. Kajstura, B. Nadal-Ginard, and P. Anversa Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure Circ. Res., February 16, 2001; 88(3): 298 - 304. [Abstract] [Full Text] [PDF]

				G. J. Wehbi, J. Zimpelmann, R. M. Carey, D. Z. Levine, and K. D. Burns Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors Am J Physiol Renal Physiol, February 1, 2001; 280(2): F254 - F265. [Abstract] [Full Text] [PDF]

				M. Akishita, M. Iwai, L. Wu, L. Zhang, Y. Ouchi, V. J. Dzau, and M. Horiuchi Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice Circulation, October 3, 2000; 102(14): 1684 - 1689. [Abstract] [Full Text] [PDF]

				S. Busche, S. Gallinat, R.-M. Bohle, A. Reinecke, J. Seebeck, F. Franke, L. Fink, M. Zhu, C. Sumners, and T. Unger Expression of Angiotensin AT1 and AT2 Receptors in Adult Rat Cardiomyocytes after Myocardial Infarction : A Single-Cell Reverse Transcriptase-Polymerase Chain Reaction Study Am. J. Pathol., August 1, 2000; 157(2): 605 - 611. [Abstract] [Full Text] [PDF]

				Yi Xu, V. Menon, and B. I Jugdutt Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195. [Abstract] [PDF]

				S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners The angiotensin II type 2 receptor: an enigma with multiple variations Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374. [Abstract] [Full Text] [PDF]

				R. Ozono, T. Matsumoto, T. Shingu, T. Oshima, Y. Teranishi, M. Kambe, H. Matsuura, G. Kajiyama, Z.-Q. Wang, A. F. Moore, et al. Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R781 - R789. [Abstract] [Full Text] [PDF]

				R. M. Carey, Z.-Q. Wang, and H. M. Siragy Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function Hypertension, January 1, 2000; 35(1): 155 - 163. [Abstract] [Full Text] [PDF]

				S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors Circ. Res., November 12, 1999; 85(10): 919 - 930. [Abstract] [Full Text] [PDF]

				K. C Wollert and H. Drexler The renin-angiotensin system and experimental heart failure Cardiovasc Res, September 1, 1999; 43(4): 838 - 849. [Abstract] [Full Text] [PDF]

				Z.-Q. Wang, L. J. Millatt, N. T. Heiderstadt, H. M. Siragy, R. A. Johns, and R. M. Carey Differential Regulation of Renal Angiotensin Subtype AT1A and AT2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension Hypertension, January 1, 1999; 33(1): 96 - 101. [Abstract] [Full Text] [PDF]

				R. M. Touyz, D. Endemann, G. He, J.-S. Li, and E. L. Schiffrin Role of AT2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR Hypertension, January 1, 1999; 33(1): 366 - 372. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Z.-Q. Articles by Carey, R. M. Search for Related Content PubMed PubMed Citation Articles by Wang, Z.-Q. Articles by Carey, R. M.